Bevacizumab and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer

Clinical trial NCT00055861 · COMPLETED

Trial details

NCT number: NCT00055861
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Breast Cancer Stage IV Breast Cancer

Start date: 2002-07-01
Primary completion: 2006-08-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.